The presence of activated complement in human brain tissues from AD patients suggests a role of complement in the inflammatory CNS environment (100); it is mainly associated with the Aβ plaques (C1q, C3 and C4) and to a lesser extent with neurofibrillary tangles and dystrophic neurites. This evidence concerns the gene C3 and Alzheimer disease.